Impacts of microRNA-155 on the Expression of Interleukin-1β and Tumor Suppressor Gene JADE-1 in Iraqi Women with Cervical Cancer

Aseel Shakir Mahmood; Yasir Wisam Issa

doi:10.54133/ajms.v7i1(Special).869

Authors

Aseel Shakir Mahmood Department of Biotechnology, College of Science, University of Baghdad, Baghdad, Iraq https://orcid.org/0009-0007-1607-5073
Yasir Wisam Issa Department of Anesthesia and Intensive Care Techniques, Madenat Alelem University College, Baghdad, Iraq https://orcid.org/0000-0001-5427-0602

DOI:

https://doi.org/10.54133/ajms.v7i1(Special).869

Keywords:

Cervical cancer, ELISA, IL-1β, miR-155, JADE-1, qRT-PCR

Abstract

Background: Cervical cancer poses a significant health challenge globally, with an increase in nations with poor or medium incomes, including Iraq. Objective: This study investigates the molecular interaction between microRNA-155 (miR-155-5p), interleukin-1β (IL-1β), and the tumor suppressor gene JADE-1, exploring their roles in the pathogenesis of cervical cancer among Iraqi women. Methods: By analyzing samples from 40 cervical cancer patients and 40 healthy controls, the study investigated the expression levels of miR-155-5p and its impact on IL-1β and JADE-1 through qRT-PCR and ELISA techniques. Results: The study reveals a significant upregulation of miR-155-5p in patients compared to controls, alongside a notable downregulation of JADE-1. While slightly elevating the serum level of IL-1β (p>0.05). These changes at the molecular level point to miR-155-5p possibly playing a role in cancer by creating an inflammatory environment around the tumor and decreasing the activity of pathways that stop tumors from growing through JADE-1. Conclusions: The study paves the way for further exploration into the mechanistic pathways of these molecules, offering potential biomarkers for early detection, prognosis, and the development of targeted therapies, thus aiming to improve the management and outcomes for women afflicted with cervical cancer in Iraq.

Downloads

Download data is not yet available.

References

Tang Y, Zhao Y, Ran J, Wang Y. MicroRNA-21 promotes cell metastasis in cervical cancer through modulating epithelial-mesenchymal transition. Oncol Lett. 2020;19:3289-3295. doi: 10.3892/ol.2020.11438.

Wu S, Hu G, Chen J, Xie G. Interleukin 1β and interleukin 1 receptor antagonist gene polymorphisms and cervical cancer: a meta-analysis. Int J Gynecol Cancer. 2014;24(6):984-990. doi: 10.1097/IGC.0000000000000165.

Rébé C, Ghiringhelli F. Interleukin-1β and cancer. Cancers. 2020;12:1791. doi: 10.3390/cancers12071791.

Park S, Eom K, Kim J, Bang H, Wang H, Ahn S, et al. MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer. BMC Cancer. 2017;17. doi: 10.1186/s12885-017-3642-5.

Zhou MI, Foy RL, Chitalia VC, Zhao J, Panchenko MV, Wang H, et al. Jade-1, a candidate renal tumor suppressor that promotes apoptosis. Proc Natl Acad Sci U S A. 2005 [cited 2024;102:11035–11040. doi: 10.1073/pnas.0500757102.

Jihad NA, Issa YW. Role of microRNA-155 as a diagnostic biomarker for human papillomavirus associated cervical cancer. Wiadomosci Lekarskie. 2021;74(9 cz 2):2301-234. doi: 10.36740/WLek202109210.

Xiao-Fen W, Ting C, Jie L, Deng-Yang M, Qing-Feng Z, Xin L. Correlation analysis of VHL and Jade-1 gene expression in human renal cell carcinoma. Open Med. (Poland). 2016;11:226–230. doi: 10.1515/med-2016-0043.

Kim G, Cho H, Lee D, Park S, Lee J, Wang H, et al. Comparison of FFPE histological versus LBP cytological samples for HPV detection and typing in cervical carcinoma. Exp Mol Pathol. 2017;102:321–326. doi: 10.1016/j.yexmp.2017.02.015.

Del Mar Díaz-González S, Rodríguez-Aguilar ED, Meneses-Acosta A, Valadez-Graham V, Deas J, Gómez-Cerón C, et al. Transregulation of microRNA miR-21 promoter by AP-1 transcription factor in cervical cancer cells. Cancer Cell Int. 2019;19:214. doi: 10.1186/s12935-019-0931-x.

Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 CT method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262.

Lee CH, Chang JS, Syu SH, Wong TS, Chan JY, Tang YC, et al. IL‐1β promotes malignant transformation and tumor aggressiveness in oral cancer. J Cell Physiol. 2015;230(4):875-884. doi: 10.1002/jcp.24816.

Lee CH, Chang JSM, Syu SH, Wong TS, Chan JYW, Tang YC, et al. IL-1β promotes malignant transformation and tumor aggressiveness in oral cancer. J Cell Physiol. 2015;230:875–884. doi: 10.1002/jcp.24816.

Chen G, Wang D, Zhao X, Cao J, Zhao Y, Wang F, et al. miR-155-5p modulates malignant behaviors of hepatocellular carcinoma by directly targeting CTHRC1 and indirectly regulating GSK-3β-involved Wnt/β-catenin signaling. Cancer Cell Int. 2017;17. doi: 10.1186/s12935-017-0469-8.

Zhou J, Wang H, Che J, Xu L, Yang W, Li Y, et al. Silencing of microRNA-135b inhibits invasion, migration, and stemness of CD24+CD44+ pancreatic cancer stem cells through JADE-1-dependent AKT/mTOR pathway. Cancer Cell Int. 2020;20. doi: 10.1186/s12935-020-01210-1.

Xu W, Song C, Wang X, Li Y, Bai X, Liang X, et al. Downregulation of miR-155-5p enhances the anti-tumor effect of cetuximab on triple-negative breast cancer cells via inducing cell apoptosis and pyroptosis. Aging (Albany NY). 2021;13:228. doi: 10.18632/aging.103669.

Kapral M, Wawszczyk J, Wȩglarz L. Regulation of microRNA-155 and its related genes expression by inositol hexaphosphate in colon cancer cells. Molecules. 2019;24:4153. doi: 10.3390/molecules24224153.

Aseel SM, Omar SS, Mohamed SS. Uranium concentration variation dependency on gender correlated with age of bladder cancer patient. Int J Res Pharm Sci. 2019;10(3):1730-1734. doi: 10.26452/ijrps.v10i3.1363.

Ad’hiah AH, Mahmood AS, Al-Kazaz A-KA, Mayouf KK. Gene expression and polymorphism of interleukin-4 in a sample of Iraqi rheumatoid arthritis patients. Baghdad Sci J. 2018;15:130. doi: 10.21123/bsj.2018.15.2.0130.

Mahmood AS, Al-Kazaz A-KA, Ad’hiah AH. Single nucleotide polymorphism of IL1B gene (rs16944) in a sample of rheumatoid arthritis Iraqi patients. Iraqi J Sci. 2018;1041–1045. doi: 10.24996/ijs.2018.59.2C.7.

Al-Janabi II. CAR-T Cell Therapy for cancer. Al-Rafidain J Med Sci. 2024;6(2):21-31. doi: 10.54133/ajms.v6i2.726.